Thromboembolic complications of cancer: Epidemiology, pathogenesis, diagnosis, and treatment
- 30 December 2002
- journal article
- review article
- Published by Wiley in American Journal of Hematology
- Vol. 72 (1) , 43-52
- https://doi.org/10.1002/ajh.10263
Abstract
The association between malignancy and clinical thrombosis has been recognized for nearly 140 years. The purpose of this review is to examine our current understanding of thrombosis as a complication of cancer and cancer therapy. The review includes a discussion of the epidemiology, pathophysiology, diagnosis and treatment. Am. J. Hematol. 72:43–52, 2003.Keywords
This publication has 75 references indexed in Scilit:
- Treatment of patients with venous thromboembolism and malignant disease: Should vena cava filter placement be routine?Journal of Vascular Surgery, 1998
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous ThromboembolismNew England Journal of Medicine, 1997
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerThe Lancet, 1994
- Therapy of venous thromboembolism in patients with brain metastasesCancer, 1994
- Tissue factor as a tumor procoagulantCancer and Metastasis Reviews, 1992
- Thrombosis and the HeartSeminars in Neurology, 1991
- The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast CancerNew England Journal of Medicine, 1988
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982
- TAMOXIFEN AND THROMBOSISThe Lancet, 1978